Matched unrelated donor. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Antilymphocyte Serum Fetal Blood Allografts Transplants T-Lymphocytes Philadelphia Chromosome Neutrophils Hematopoietic Stem Cells Killer Cells, Natural

Organisms2

Transplantation Chimera Cytomegalovirus

Diseases35

Graft vs Host Disease Hematologic Neoplasms Leukemia Anemia, Aplastic Recurrence Precursor Cell Lymphoblastic Leukemia-Lymphoma Leukemia, Myelogenous, Chronic, BCR-ABL Positive Hematologic Diseases Myelodysplastic Syndromes Acute Disease Leukemia, Myeloid, Acute Histiocytosis, Non-Langerhans-Cell Infection Wiskott-Aldrich Syndrome Severe Combined Immunodeficiency Metabolism, Inborn Errors Fanconi Anemia Cytomegalovirus Infections Leukemia, Myelomonocytic, Acute Anemia, Refractory, with Excess of Blasts Cadaver Chronic Disease Genetic Diseases, Inborn Leukemia, Myeloid Lymphoproliferative Disorders Immunologic Deficiency Syndromes Hepatic Veno-Occlusive Disease Lymphoma Philadelphia Chromosome Opportunistic Infections Neoplasm, Residual Lymphoma, Non-Hodgkin Neoplasm Recurrence, Local Multiple Myeloma Brain Death

Chemicals and Drugs31

HLA Antigens Antilymphocyte Serum Vidarabine Myeloablative Agonists HLA-DP beta-Chains Immunosuppressive Agents Busulfan HLA-DP Antigens HLA-A Antigens Cyclosporine HLA-B Antigens HLA-C Antigens Methotrexate Tacrolimus HLA-DRB1 Chains Melphalan Mycophenolic Acid Cyclophosphamide HLA-DR Antigens Antibodies, Neoplasm Methylprednisolone Receptors, KIR Granulocyte Colony-Stimulating Factor Thiotepa HLA-DQ Antigens Antigens, CD34 Antibodies, Monoclonal Histocompatibility Antigens Class I Cytarabine Antineoplastic Agents Antibodies, Monoclonal, Humanized

Analytical, Diagnostic and Therapeutic Techniques and Equipment57

Histocompatibility Testing Transplantation, Homologous Bone Marrow Transplantation Transplantation Conditioning Hematopoietic Stem Cell Transplantation Cord Blood Stem Cell Transplantation Treatment Outcome Peripheral Blood Stem Cell Transplantation Donor Selection Survival Analysis Whole-Body Irradiation Disease-Free Survival Retrospective Studies Survival Rate Lymphocyte Depletion Hemibody Irradiation Life Tables Remission Induction Stem Cell Transplantation Actuarial Analysis Registries Follow-Up Studies Kidney Transplantation Cause of Death Transplantation, Autologous Risk Factors Lymphocyte Transfusion Incidence Immunosuppression Transplantation, Isogeneic Prognosis Salvage Therapy Blood Cell Count Combined Modality Therapy Blood Preservation Prospective Studies Polymerase Chain Reaction Multivariate Analysis Proportional Hazards Models Hematopoietic Stem Cell Mobilization Kaplan-Meier Estimate Lymphocyte Count Cohort Studies Leukocyte Count Risk Liver Transplantation Platelet Count Fatal Outcome Treatment Failure Pedigree Antineoplastic Combined Chemotherapy Protocols Probability Tissue and Organ Harvesting Drug Therapy, Combination Feasibility Studies DNA Mutational Analysis Insemination, Artificial, Heterologous

Psychiatry and Psychology3

Siblings Nuclear Family Family

Phenomena and Processes27

Histocompatibility Graft Survival Graft Rejection Transplantation Immunology Time Factors Alleles Graft vs Leukemia Effect Graft vs Tumor Effect Haplotypes Chimerism Blood Cell Count Genotype Philadelphia Chromosome Lymphocyte Count Polymorphism, Genetic Leukocyte Count Risk Genes, MHC Class I Immunocompromised Host Platelet Count Major Histocompatibility Complex Base Sequence Mutation Hematopoiesis Probability Amino Acid Sequence Phenotype

Anthropology, Education, Sociology and Social Phenomena3

Siblings Nuclear Family Family

Information Science9

Survival Rate Life Tables Registries Cause of Death Incidence Molecular Sequence Data Fatal Outcome Base Sequence Amino Acid Sequence

Named Groups6

Unrelated Donors Tissue Donors Living Donors Blood Donors Siblings Infant, Newborn

Health Care26

Treatment Outcome Donor Selection Survival Analysis Disease-Free Survival Retrospective Studies Survival Rate Tissue and Organ Procurement Directed Tissue Donation Life Tables Actuarial Analysis Registries Follow-Up Studies Cause of Death Risk Factors Incidence Prospective Studies Multivariate Analysis Proportional Hazards Models Kaplan-Meier Estimate Age Factors Cohort Studies Risk Fatal Outcome Treatment Failure Probability Feasibility Studies

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Unrelated Donors Tissue Donors Histocompatibility Testing Graft vs Host Disease Histocompatibility Transplantation, Homologous Bone Marrow Transplantation Transplantation Conditioning Hematopoietic Stem Cell Transplantation Hematologic Neoplasms Living Donors Blood Donors Cord Blood Stem Cell Transplantation HLA Antigens Graft Survival Leukemia Anemia, Aplastic Recurrence Treatment Outcome Antilymphocyte Serum Peripheral Blood Stem Cell Transplantation Donor Selection Vidarabine Survival Analysis Myeloablative Agonists Siblings Whole-Body Irradiation Disease-Free Survival Precursor Cell Lymphoblastic Leukemia-Lymphoma HLA-DP beta-Chains Transplantation Chimera Immunosuppressive Agents Busulfan Retrospective Studies Leukemia, Myelogenous, Chronic, BCR-ABL Positive Hematologic Diseases Survival Rate Fetal Blood Lymphocyte Depletion Myelodysplastic Syndromes Acute Disease Graft Rejection HLA-DP Antigens Hemibody Irradiation Leukemia, Myeloid, Acute Transplantation Immunology Tissue and Organ Procurement Allografts HLA-A Antigens Directed Tissue Donation Life Tables Remission Induction Cyclosporine Stem Cell Transplantation Actuarial Analysis Histiocytosis, Non-Langerhans-Cell HLA-B Antigens HLA-C Antigens Methotrexate Tacrolimus Infection Registries Transplants Time Factors Follow-Up Studies Kidney Transplantation Wiskott-Aldrich Syndrome Cause of Death Severe Combined Immunodeficiency HLA-DRB1 Chains Metabolism, Inborn Errors Transplantation, Autologous Alleles Graft vs Leukemia Effect T-Lymphocytes Risk Factors Fanconi Anemia Cytomegalovirus Infections Graft vs Tumor Effect Melphalan Lymphocyte Transfusion Mycophenolic Acid Cyclophosphamide Incidence Immunosuppression Leukemia, Myelomonocytic, Acute HLA-DR Antigens Antibodies, Neoplasm Haplotypes Anemia, Refractory, with Excess of Blasts Cadaver Chronic Disease Methylprednisolone Chimerism Transplantation, Isogeneic Infant, Newborn Genetic Diseases, Inborn Prognosis Receptors, KIR Leukemia, Myeloid

No FAQ available that match "matched unrelated donor"